Popular on Amzeal
- Appeals Court Reverses Judge and Rules Against ACS - 228
- FCTI, Inc. Announces John Grosheim as New Director of Security - 226
- G. ENTERTAINMENT proudly presents Indianapolis' Inaugural Juneteenth Celebration Weekend Kick-Off with the "What the Funk" Concert
- What Is an Endodontist? Do I Need A Root Canal?
- Football is Serious Business for California High School Standout James "Bo" Thomas III
- WWO Welcomes New Board And Staff Members
- JagKumar Wins Direct Award From Dallas Area Rapid Transit (DART)
- CHRIS JASPER "Raises The Bar" with the June Release of his New Music!
- Terrorism is again on the rise warnings in new TERROR STRIKES book release
- Phantom 32" touchscreen LCD monitor now available separately
Similar on Amzeal
- Mutual Aid Ambulance Service Partners with Excela Health for Paramedic Training Program
- Avion Medical Skin Centres to offer innovative treatment for non-melanoma skin cancer patients
- iTech offers 60-days free trial on expEDIum Medical Billing® product
- CPC Scientific Announces New California Peptide API Manufacturing Facility
- Calgary-based Orthodontics Provider Opens New Location
- Console & Associates: The Passing of the Camp Lejeune Act Puts Justice Within Reach
- Console & Associates, P.C. Explores Legal Options for Camp Lejeune Veterans and Families
- DocVilla launches Appointment Reminder Call feature for Medical Practices
- Perth skin cancer patients undergo first treatments with OncoBeta's Rhenium-SCT as part of the EPIC-Skin study
- Nutrition and Wellness Expert, Chaitra Dalton Bryant Joins the Board of the National Minority Health Association to Reduce Health Inequities
Accel Research Sites recruiting for Alzheimer's prevention trial
Amzeal News/10476327
Accel Research Sites is recruiting for an Alzheimer's prevention trial, Patients ages 55-80 with no symptoms are eligible.
TAMPA, Fla. - Amzeal -- When many people think of Alzheimer's Disease, they think of the later stage cognitive decline. But changes to the brain can actually start 10 to 20 years before symptoms appear.
A clinical trial in Tampa is aiming to prevent or slow those symptoms before a patient is even diagnosed. The trial is testing an investigational medicine that may prevent or slow Alzheimer's Disease in patients who currently do not have symptoms. Participants in the trial might also be able to learn if they have a specific biomarker believed to be present in patients with Alzheimer's Disease.
Accel Research Sites is now recruiting patients 55 to 80 for this important clinical trial.
"People often think clinical trials are for people who are sick," said Lora Parahovnik, CEO of Accel Research Sites. "But there are many trials for healthy volunteers, and there are also trials like this that aim to prevent diseases. In fact, this trial can even show participants if they are at risk of developing a disease. Trials like this are essential in helping to move medicine forward for current and future patients."
More on Amzeal News
Both men and women are eligible for the trial. They must have normal memory and thinking and have a reliable study partner who can report if there are any changes in day-to-day life. Participants must live within a 35-mile radius of the testing site, 5411 Beaumont Center Blvd. Suite 760, Tampa, FL 33634. Dr. Deborah Burke is the principal investigator.
Study-related care will be provided at no cost to eligible participants. Insurance is not required, and compensation may be available.
Those interested in learning more can visit https://accelresearchsites.com/get-started/.
For more information about Accel Research Sites, visit https://accelresearchsites.com/.
A clinical trial in Tampa is aiming to prevent or slow those symptoms before a patient is even diagnosed. The trial is testing an investigational medicine that may prevent or slow Alzheimer's Disease in patients who currently do not have symptoms. Participants in the trial might also be able to learn if they have a specific biomarker believed to be present in patients with Alzheimer's Disease.
Accel Research Sites is now recruiting patients 55 to 80 for this important clinical trial.
"People often think clinical trials are for people who are sick," said Lora Parahovnik, CEO of Accel Research Sites. "But there are many trials for healthy volunteers, and there are also trials like this that aim to prevent diseases. In fact, this trial can even show participants if they are at risk of developing a disease. Trials like this are essential in helping to move medicine forward for current and future patients."
More on Amzeal News
- ESL Model 9478 Dual 4-Channel RJ45 Cat5e A/B, Manual Keylock Switch with Simultaneous Control
- Wbuild to launch marketplace for tokenized real estate investments where anyone can invest from $50
- BookingPal Integrates Airbnb Messaging to Launch New Communication Feature
- Web Scribble is the Latest Authorized iMIS Product Partner
- Pikmykid and FACTS Announce Partnership to Advance School Safety and Efficiency
Both men and women are eligible for the trial. They must have normal memory and thinking and have a reliable study partner who can report if there are any changes in day-to-day life. Participants must live within a 35-mile radius of the testing site, 5411 Beaumont Center Blvd. Suite 760, Tampa, FL 33634. Dr. Deborah Burke is the principal investigator.
Study-related care will be provided at no cost to eligible participants. Insurance is not required, and compensation may be available.
Those interested in learning more can visit https://accelresearchsites.com/get-started/.
For more information about Accel Research Sites, visit https://accelresearchsites.com/.
Source: Accel Research Sites
Filed Under: Medical
0 Comments
Latest on Amzeal News
- New Hampshire Becomes the 15th State to Require Personal Finance as a Core Academic Subject
- Virtual Workplace Platform Developer REACH Expands Executive Team, Positioning the Company to Drive International Growth
- GitKon 2022: Tech Conference Turned TikTok
- Axiomtek's SDM300S Verified as Panasonic Professional Display Compatible Smart Display Module
- Think Systems, Inc. Preps for Growth by Adding Frank Leone to Director of Strategic Partnerships
- Health Advisory: Protecting Yourself and Others from Monkeypox
- NFT.Kred's Cameron Bale, OpenSea's Devin Finzer, and PeopleBrowsr's Jodee Rich Welcome NFT Innovators and Creators to NFT.NYC 2022
- Kindle FREE June 28-29: Powerful new memoir from Santa Molina-Marshall poised to help heal abuse victims through inspiring storytelling
- GoodLoan.io announces new program to unlock up to $500,000 for Home Equity Investment
- Beck Properties Group Hires Professional Marketing Team
- Cosplay Universe" Documentary to Premiere at Anime Expo & in Theaters this Summer
- Joseph Federico, Director of NJMET, Inc., Honors Gauri Rana for 15 Years of Service
- Kano Laboratories, Makers of Kroil, Announces Refreshed Branding for Extended Line of Industrial Product Solutions
- New 5" TFT Displays with IPS Technology at Newhaven Display
- ESL QuickSwitch® Model 6240 Duplex POF A/B Conector Switch with Serial Remote Control
- Study Uncovers Crucial Insights for Technology Sales Leaders
- Fathym announces the addition of Sergio Sotolongo to its board of directors
- Prolific Author Tam R. Luc Celebrates Positive Title IX Achievements and Pushes Businesswomen to the Next Level with Boss Up Summit
- Avion Medical Skin Centres to offer innovative treatment for non-melanoma skin cancer patients
- Launch of Def Leppard beauty collection creating Hysteria in the makeup industry